MetSense pilot study for serious mental illness
Part of Hormones & metabolism clinical trials.
This pilot study is testing a program for people with serious mental illness like schizophrenia or bipolar disorder. It aims to see if adding a special monitoring tool helps manage treatment better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have been diagnosed with schizophrenia, another psychotic disorder, or bipolar disorder.
- You must be part of Kaiser Permanente Northern California's clinical pharmacist program for serious mental illness.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether mindfulness-based therapy helps people with serious mental illnesses like schizophrenia or mood disorders. You'll learn mindfulness skills in a group setting at your community mental health center.
This trial tests a team-based program that combines diabetes care with mental health support. It aims to help you better manage both your diabetes and emotional well-being through remote check-ins and coaching.
This study helps people with serious mental illness like schizophrenia or bipolar disorder who also have chronic health conditions (e.g., diabetes, overweight) get better overall care. It focuses on improving health and wellness through preventive medical care in Puerto Rico.
This study tests a program to help people with type 2 diabetes living in rural areas better manage their condition. It uses a smartphone app and coaching to improve blood sugar control.
This trial tests a program that combines mindfulness training with diabetes education, all done from home remotely. It aims to help Black adults with type 2 diabetes who are feeling stressed about their condition and have high blood sugar.
This trial tests a long-term program to improve heart and metabolic health in adults with schizophrenia or related disorders. It may help reduce health risks often linked with severe mental illness.
Hear when a new Serious Mental Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.